Renaissance Technologies - UNUM THERAPEUTICS INC ownership

UNUM THERAPEUTICS INC's ticker is UMRX and the CUSIP is 903214104. A total of 35 filers reported holding UNUM THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of UNUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$817,000
+49.1%
349,066
-70.7%
0.00%
Q2 2020$548,000
+402.8%
1,191,402
+352.0%
0.00%
Q1 2020$109,000
-57.3%
263,604
-25.6%
0.00%
Q4 2019$255,000
+1242.1%
354,458
+2626.6%
0.00%
Q3 2019$19,000
-84.2%
13,000
-71.7%
0.00%
Q2 2019$120,000
-59.5%
45,900
-31.9%
0.00%
Q1 2019$296,000
+52.6%
67,363
+53.1%
0.00%
Q4 2018$194,000
-73.2%
44,000
-37.3%
0.00%
-100.0%
Q3 2018$723,00070,2000.00%
Other shareholders
UNUM THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 3,361,535$14,757,00013.86%
New Leaf Venture Partners, L.L.C. 1,795,545$7,882,0002.16%
SECTORAL ASSET MANAGEMENT INC 1,587,437$6,969,0000.84%
SABBY MANAGEMENT, LLC 206,358$906,0000.44%
COWEN INC. 817,395$3,588,0000.38%
Novo Holdings A/S 473,441$2,078,0000.31%
PLATINUM INVESTMENT MANAGEMENT LTD 260,595$1,144,0000.03%
WASATCH ADVISORS LP 254,449$1,117,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 109,075$479,0000.01%
FIL Ltd 783,423$3,439,0000.01%
View complete list of UNUM THERAPEUTICS INC shareholders